Stability and Inhibitory Activity of Pediocin PA-1 Against Listeria sp. in Simulated Physiological Conditions of the Human Terminal Ileum

Probiotics and Antimicrobial Proteins

Volumn 4, Issue 4, 2012, Pages 250-258

  Le Blay, Gwenaëlle ^c   Hammami, Riadh ^b   Lacroix, Christophe ^a   Fliss, Ismaïl ^b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITÉ LAVAL   (Canada)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

Bacteriocins; Ileum; Intestinal bacteria; Listeria; Pediocin PA 1

Indexed keywords

PEDIOCIN; PEDIOCIN PA 1; UNCLASSIFIED DRUG;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; CLOSTRIDIUM; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; ILEUM; INTESTINE FLORA; LISTERIA IVANOVII; LISTERIOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIOCOCCUS ACIDILACTICI; PH; PRIORITY JOURNAL;

LISTERIA; LISTERIA IVANOVII; LISTERIA MONOCYTOGENES; PEDIOCOCCUS ACIDILACTICI;

EID: 84870672926     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-012-9111-1     Document Type: Article

References (58)

1. Abee T, Krockel L, Hill C (1995) Bacteriocins: modes of action and potentials in food preservation and control of food poisoning. Int J Food Microbiol 28: 169-185.
2. Ahmed S, Macfarlane GT, Fite A, McBain AJ, Gilbert P, Macfarlane S (2007) Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol 73: 7435-7442.
3. Allende A, Martínez B, Selma V, Gil MI, Suárez JE, Rodríguez A (2007) Growth and bacteriocin production by lactic acid bacteria in vegetable broth and their effectiveness at reducing Listeria monocytogenes in vitro and in fresh-cut lettuce. Food Microbiol 24: 759-766.
4. Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA (2004) The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 40: 223-229.
5. Bambirra FH, Lima KG, Franco BD, Cara DC, Nardi RM, Barbosa FH, Nicoli JR (2007) Protective effect of Lactobacillus sakei 2a against experimental challenge with Listeria monocytogenes in gnotobiotic mice. Lett Appl Microbiol 45: 663-667.
6. Beerens H (1990) An elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 11: 155-157.
7. Benech R-O, Kheadr EE, Lacroix C, Fliss I (2002) Antibacterial activities of nisin Z encapsulated in liposomes or produced in situ by mixed culture during cheddar cheese ripening. Appl Environ Microbiol 68: 5607-5619.
8. Cinquin C, Le Blay G, Fliss I, Lacroix C (2006) New three-stage in vitro model for infant colonic fermentation with immobilized fecal microbiota. FEMS Microbiol Ecol 57: 324-336.
9. Cintas LM, Casaus MP, Herranz C, Nes IF, Hernandez PE (2001) Review: bacteriocins of lactic acid bacteria. Food Sci Technol Int 7: 281-305.
10. Cleusix V, Lacroix C, Vollenweider S, Le Blay G (2008) Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces. FEMS Microbiol Ecol 63: 56-64.
11. Conlan JW (1997) Neutrophils and tumour necrosis factor-α are important for controlling early gastrointestinal stages of experimental murine listeriosis. J Med Microbiol 46: 239-250.
12. Corr SC, Gahan CGM, Hill C (2007) Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol 50: 380-388.
13. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CGM (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci 104: 7617-7621.
14. Cutter CN, Siragusa GR (1998) Incorporation of nisin into a meat binding system to inhibit bacteria on beef surfaces. Lett Appl Microbiol 27: 19-23.
15. Daba H, Lacroix C, Huang J, Simard RE, Lemieux L (1994) Simple method of purification and sequencing of a bacteriocin produced by Pediococcus acidilactici UL5. J Appl Bacteriol 77: 682-688.
16. Dabour N, Zihler A, Kheadr E, Lacroix C, Fliss I (2009) In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes. Int J Food Microbiol 133: 225-233.
17. Dabour N, Zihler A, Kheadr E, Lacroix C, Fliss I (2009) In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes. Int J Food Microbiol 133: 225-233.
18. Dobson A, Crispie F, Rea MC, O'Sullivan O, Casey PG, Lawlor PG, Cotter PD, Ross P, Gardiner GE, Hill C (2011) Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol Ecol 76: 602-614.
19. Drider D, Fimland G, Hechard Y, McMullen LM, Prevost H (2006) The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 70: 564-582.
20. Drouault S, Corthier G, Ehrlich SD, Renault P (1999) Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 65: 4881-4886.
21. Fallingborg J (1999) Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 46: 183-196.
22. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64: 3336-3345.
23. Gibson GR, Wang X (1994) Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118: 121-127.
24. Gordon DM, Oliver E, Littlefield-Wyer J (2007) The diversity of bacteriocins in Gram-negative bacteria. In: Riley MA, Chavan M (eds) Bacteriocins: ecology and evolution. Springer, Berlin, pp 5-18.
25. Hammami R, Zouhir A, Le Lay C, Ben Hamida J, Fliss I (2010) BACTIBASE second release: a database and tool platform for bacteriocin characterization. BMC Microbiol 10: 22.
26. Hammami R, Zouhir A, Le Lay C, Ben Hamida J, Fliss I (2011) Database mining for bacteriocin discovery. In: Rai M, Chikindas M (eds) Natural antimicrobials in food safety and quality. C. A. B International, Oxfordshire, pp 349-358.
27. Harmsen HJM, Elfferich P, Schut F, Welling GW (1999) A 16S rRNA-targeted probe for detection of Lactobacilli and Enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11: 3-12.
28. Hatakka K, Saxelin M (2008) Probiotics in intestinal and non-intestinal infectious diseases-clinical evidence. Curr Pharm Des 14: 1351-1367.
29. Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y (2005) Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol 54: 1093-1101.
30. Heng NCK, Wescombe PA, Burton JP, Jack RW, Tagg JR (2007) The diversity of bacteriocins in gram-positive bacteria. In: Riley MA, Chavan M (eds) Bacteriocins: ecology and evolution. Springer, Berlin, pp 45-92.
31. Ingham A, Ford M, Moore RJ, Tizard M (2003) The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J Antimicrob Chemother 51: 1365-1371.
32. Kheadr E, Zihler A, Dabour N, Lacroix C, Le Blay G, Fliss I (2010) Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model. J Appl Microbiol 109: 54-64.
33. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling GW (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61: 3069-3075.
34. Le Blay G, Lacroix C, Zihler A, Fliss I (2007) In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacteria. Lett Appl Microbiol 45: 252-257.
35. Macfarlane GT, Cummings JH, Macfarlane S, Gibson GR (1989) Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol 67: 520-527.
36. Macfarlane GT, Hay S, Macfarlane S, Gibson GR (1990) Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. J Appl Microbiol 68: 179-187.
37. Macfarlane GT, Macfarlane S, Gibson GR (1998) Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 35: 180-187.
38. Mallory A, Kern F Jr, Smith J, Savage D (1973) Patterns of bile acids and microflora in the human small intestine. I. Bile acids. Gastroenterology 64: 26-33.
39. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer K-H (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142: 1097-1106.
40. Marteau P, Pochart P, Doré J, Béra-Maillet C, Bernalier A, Corthier G (2001) Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol 67: 4939-4942.
41. Montalban-Lopez M, Sanchez-Hidalgo M, Valdivia E, Martinez-Bueno M, Maqueda M (2011) Are bacteriocins underexploited? NOVEL applications for OLD antimicrobials. Curr Pharm Biotechnol 12: 1205-1220.
42. Naghmouchi K, Drider D, Kheadr E, Lacroix C, Prévost H, Fliss I (2006) Multiple characterizations of Listeria monocytogenes sensitive and insensitive variants to divergicin M35, a new pediocin-like bacteriocin. J Appl Microbiol 100: 29-39.
43. Naghmouchi K, Fliss I, Drider D, Lacroix C (2008) Pediocin PA-1 production during repeated-cycle batch culture of immobilized Pediococcus acidilactici UL5 cells. J Biosci Bioeng 105: 513-517.
44. Naghmouchi K, Kheadr E, Lacroix C, Fliss I (2007) Class I/Class IIa bacteriocin cross-resistance phenomenon in Listeria monocytogenes. Food Microbiol 24: 718-727.
45. Nilsson L, Nielsen MK, Ng Y, Gram L (2002) Role of acetate in production of an autoinducible class IIa bacteriocin in Carnobacterium piscicola A9b. Appl Environ Microbiol 68: 2251-2260.
46. Patzer SI, Baquero MR, Bravo D, Moreno F, Hantke K (2003) The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology 149: 2557-2570.
47. Poulsen LK, Licht TR, Rang C, Krogfelt KA, Molin S (1995) Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 177: 5840-5845.
48. Riboulet-Bisson E, Sturme MHJ, Jeffery IB, O'Donnell MM, Neville BA, Forde BM, Claesson MJ, Harris H, Gardiner GE, Casey PG, Lawlor PG, O'Toole PW, Ross RP (2012) Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One 7: e31113.
49. Riley MA, Wertz JE (2002) BACTERIOCINS: evolution, ecology, and application. Annu Rev Microbiol 56: 117-137.
50. Rodriguez JM, Martinez MI, Kok J (2002) Pediocin PA-1, a wide-spectrum bacteriocin from lactic acid bacteria. Crit Rev Food Sci Nutr 42: 91-121.
51. Salvucci E, Saavedra L, Hebert EM, Haro C, Sesma F (2012) Enterocin CRL35 inhibits Listeria monocytogenes in a murine model. Foodborne Pathog Dis 9: 68-74.
52. Schultz M (2008) Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 14: 1012-1018.
53. Shand R, Leyva K (2008) Archaeal antimicrobials: an undiscovered country. In: Norfolk BP (ed) Archaea: new models for prokaryotic biology. Caister Academic, Norfolk, pp 233-242.
54. van der Waaij LA, Harmsen HJM, Madjipour M, Kroese FGM, Zwiers M, van Dullemen HM, de Boer NK, Welling GW, Jansen PLM (2005) Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 11: 865-871.
55. Vieira LQ, Dos Santos LM, Neumann E, da Silva AP, Moura LN, Nicoli JR (2008) Probiotics protect mice against experimental infections. J Clin Gastroenterol 42(Suppl 3, Pt 2): S168-S169.
56. Vriezen JAC, Valliere M, Riley MA (2009) The evolution of reduced microbial killing. Genome Biol Evol 2009: 400-408.
57. Wang M, Ahrné S, Jeppsson B, Molin G (2005) Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 54: 219-231.
58. Willey JM, van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61: 477-501.